|
Daniel Perry serves as President & CEO of the Alliance for Aging Research.〔(Alliance for Aging Research )〕〔(Congressional Record )〕 He has a diverse background in areas including health policy, government, politics and journalism. Perry worked on Capitol Hill for more than 12 years, including serving as special assistant to the Majority Whip of the U.S. Senate. During the first Bush Administration he was appointed to the Federal Task Force on Aging Research. President Clinton named him to the Advisory Board of the White House Conference on Aging. He also served as a delegate to the White House Conferences on Aging in 1995 and 2005. He currently serves as chair of both the (ACT-AD Coalition ) (Accelerate Cure/Treatments for Alzheimer’s Disease) and the Friends of the (Institute on Aging ).〔(ACT-AD Biography )〕 Perry helped lay the groundwork for the Foundation for Accountability (FACCT) and served as chairman of its board of directors. As part of the first governing body of the American Medical Accreditation Program (AMA), he represented consumer interests, evaluating the qualifications and performances of U.S. doctors.〔(Washington University Biography )〕 Perry served as president of the (Coalition for the Advancement of Medical Research ) (CAMR) in 2004 and currently serves as the Coalition’s treasurer and vice president of finance, leading more than 100 U.S. patient groups, medical organizations and research universities fighting to advance stem cell research and regenerative medicine.〔(Coalition for the Advancement of Medical Research Board of Directors )〕 He is also an advisor for the University of Pennsylvania Medical School’s Institute on Aging and a member of the (New York Academy of Sciences ).〔(Alliance for Aging Research biography )〕 He frequently speaks about aging research and public policy topics before business, academic and public sector audiences and is widely published on these subjects. He received many awards and citations as a journalist, including a nomination for the Pulitzer Prize.〔(ACT-AD Speaker biography )〕 == Publications == Advancing Alzheimer's Disease Drug Review as a National Priority 〔(Alzheimer's & Dementia )〕 Daniel P. Perry In Pursuit of the Longevity Dividend 〔(The Scientist )〕 S. Jay Olshansky, Daniel P. Perry, Richard A. Miller, Robert N. Butler Introduction to ''Aging, Cancer, and Age-related Diseases'' 〔http://www.nyas.org/publications/annals/Detail.aspx?cid=234aeab0-79d5-411d-9284-92519f5d9556]〕 Daniel P. Perry 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Daniel Perry」の詳細全文を読む スポンサード リンク
|